WPP
CRL icon

Whalerock Point Partners’s Charles River Laboratories CRL Stock Holding History

Whalerock Point Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$568K Buy
+2,503
New +$446K 0.1% 122
2021
Q4 		– Sell
-500
Closed -$206K – 154
2021
Q3 		$206K Buy
+500
New +$208K 0.08% 140

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Whalerock Point Partners's CRL Position: Q2 2026 in Review

Whalerock Point Partners opened a new position in Charles River Laboratories (CRL) in Q2 2026: 2,503 shares worth $568K. The stake represents 0.1% of the portfolio and ranks #122 among its holdings. This is a return to the name: Whalerock Point Partners previously reported a position in CRL as recently as Q3 2021.

Whalerock Point Partners first reported a position in CRL in Q3 2021 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Whalerock Point Partners held 2,503 shares of Charles River Laboratories worth $568K as of Q2 2026.
  • Charles River Laboratories was a new Whalerock Point Partners position in Q2 2026.
  • Charles River Laboratories made up 0.1% of Whalerock Point Partners's portfolio in Q2 2026, its #122 holding.
  • Whalerock Point Partners first reported a position in Charles River Laboratories in Q3 2021 and has held it in 2 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Whalerock Point Partners's 13F filing for Q2 2026, filed 13 Aug 2026.